Sangamo Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and a Favorable Safety Profile

Click here to view

Presentation

Process and Platform Development for Production and Purification of CNS-Tropic Engineered AAV Capsids

Download PDF